Find uplifting stories about heroes, innovations, and solutions
7521 results for "vision loss"
Researchers discovered a simple fatty acid injection that restores vision in older mice by targeting an aging gene. The breakthrough could help millions facing age-related vision loss and macular degeneration.
Researchers at UC Irvine have restored failing vision in older mice using a targeted fatty acid therapy, offering new hope for treating age-related blindness. The breakthrough could one day help millions of older adults regain sight lost to macular degeneration.
After losing her husband and facing a blinding eye disease, 73-year-old Cathy refused to let geographic atrophy dim her spark. She found a treatment that's slowing her vision loss and rediscovered her independence through piano, sewing, and small daily joys.
Scientists have created a wireless retinal implant thinner than a human hair that could one day restore sight to millions living with vision loss. The breakthrough device uses safe near-infrared light instead of risky visible light, eliminating the need for bulky electronics.
Researchers at University of Rochester Medicine received NIH funding to develop a breakthrough treatment that could stop macular degeneration before it steals vision from millions of older adults. The new therapy targets a protein that drives the disease at its earliest stages.
A single injection of experimental drug Axpaxli kept vision stable for up to a year in patients with age-related blindness, potentially reducing treatment burden. The Phase 3 trial showed significantly better durability than the current standard treatment.
The FDA just approved Yuvezzi, the first dual-action eye drop that restores near vision for people over 40 without glasses or surgery. Unlike previous drops, it works for up to 10 hours with a single daily dose.
A rice-sized implant with living cells is now FDA-approved to slow vision loss in MacTel patients, offering hope to thousands losing their sight. For the first time, people with this rare retinal disease have a real chance to preserve their independence.
Scientists at Duke University used stem cells to grow specialized retinal blood vessel cells that restored vision in blind mice. The breakthrough could lead to affordable treatments for millions facing vision loss from diseases like diabetic retinopathy.
Researchers discovered molecules that protect the eye cells responsible for reading, recognizing faces, and seeing color. The breakthrough could lead to the first treatments for age-related macular degeneration, a leading cause of blindness.
Millions face vision loss from age-related macular degeneration, but simple lifestyle changes can help delay or prevent the condition. An NYU ophthalmologist shares science-backed steps anyone can take today.
Scientists discovered that separate technologies developed over 50 years to restore sight and touch actually work nearly the same way. This breakthrough could fast-track treatments for patients with untreatable vision loss and paralysis.
A common diabetes medication may protect aging eyes from one of the leading causes of blindness. People over 55 taking metformin were significantly less likely to develop macular degeneration over five years.
A new weight-loss pill from AstraZeneca helped trial participants lose nearly 12% of their body weight in just nine months, offering fresh hope in the race to make weight management easier. The tablet could soon give doctors and patients another powerful tool in fighting obesity.
Scientists discovered that erucamide, a naturally occurring molecule in the eye, helps coordinate the retina's defense against damage and could slow degenerative eye diseases affecting millions. The breakthrough offers hope for a new approach to treating conditions like macular degeneration and diabetic retinopathy.
A cheap, widely available diabetes medication could save millions from the most common cause of blindness in older adults. Researchers found metformin reduces age-related macular degeneration progression by more than a third.
A man blind for three years unexpectedly recovered partial natural vision during a clinical trial for an artificial vision device in Spain. The spontaneous improvement persisted even after doctors removed the brain implant.
A tiny molecule discovered using AI mimics Ozempic's weight loss effects without the nausea, constipation, or muscle loss. Animal studies show the peptide targets only the brain's appetite center, not the entire digestive system.
New research challenges concerns that popular GLP-1 medications like Wegovy and Zepbound cause excessive muscle loss. The findings offer reassurance to millions considering or using these breakthrough weight-loss treatments.
Nine-year-old Prophet Ndungu was scared of burning toast, but that didn't stop him from making French toast at a Kansas City cooking class designed for blind and visually impaired kids. The program teaches young people essential kitchen skills so they can cook independently at home.
Showing 20 of 7521